TY - JOUR
T1 - Genetic/Familial high-risk assessment
T2 - Colorectal, version 2.2019 featured updates to the NCCN guidelines
AU - Gupta, Samir
AU - Provenzale, Dawn
AU - Llor, Xavier
AU - Halverson, Amy L.
AU - Grady, William
AU - Chung, Daniel C.
AU - Haraldsdottir, Sigurdis
AU - Markowitz, Arnold J.
AU - Slavin, Thomas P.
AU - Hampel, Heather
AU - Ness, Reid M.
AU - Weiss, Jennifer M.
AU - Ahnen, Dennis J.
AU - Chen, Lee May
AU - Cooper, Gregory
AU - Early, Dayna S.
AU - Giardiello, Francis M.
AU - Hall, Michael J.
AU - Hamilton, Stanley R.
AU - Kanth, Priyanka
AU - Klapman, Jason B.
AU - Lazenby, Audrey J.
AU - Lynch, Patrick M.
AU - Mayer, Robert J.
AU - Mikkelson, June
AU - Peter, Shajan
AU - Regenbogen, Scott E.
AU - Dwyer, Mary A.
AU - Ogba, Ndiya
N1 - Publisher Copyright:
© National Comprehensive Cancer Network, Inc. 2019. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Identifying individuals with hereditary syndromes allows for improved cancer surveillance, risk reduction, and optimized management. Establishing criteria for assessment allows for the identification of individuals who are carriers of pathogenic genetic variants. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provide recommendations for the assessment and management of patients with high-risk colorectal cancer syndromes. These NCCN Guidelines Insights focus on criteria for the evaluation of Lynch syndrome and considerations for use of multigene testing in the assessment of hereditary colorectal cancer syndromes.
AB - Identifying individuals with hereditary syndromes allows for improved cancer surveillance, risk reduction, and optimized management. Establishing criteria for assessment allows for the identification of individuals who are carriers of pathogenic genetic variants. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provide recommendations for the assessment and management of patients with high-risk colorectal cancer syndromes. These NCCN Guidelines Insights focus on criteria for the evaluation of Lynch syndrome and considerations for use of multigene testing in the assessment of hereditary colorectal cancer syndromes.
KW - Adenomatous Polyposis Coli/diagnosis
KW - Colorectal Neoplasms/diagnosis
KW - Diagnosis, Differential
KW - Genetic Association Studies
KW - Genetic Predisposition to Disease
KW - Humans
KW - Neoplastic Syndromes, Hereditary/diagnosis
KW - Risk Assessment
UR - http://www.scopus.com/inward/record.url?scp=85071737330&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000487242700003&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.6004/jnccn.2019.0044
DO - 10.6004/jnccn.2019.0044
M3 - Article
C2 - 31487681
SN - 1540-1405
VL - 17
SP - 1032
EP - 1041
JO - Journal of the National Comprehensive Cancer Network : JNCCN
JF - Journal of the National Comprehensive Cancer Network : JNCCN
IS - 9
ER -